These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25978645)

  • 1. Binding mode of inhibitors and Cryptosporidium parvum IMP dehydrogenase: A combined ligand- and receptor-based study.
    Li RJ; Wang YL; Wang QH; Huang WX; Wang J; Cheng MS
    SAR QSAR Environ Res; 2015; 26(5):421-38. PubMed ID: 25978645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.
    Lee S; Ku AF; Vippila MR; Wang Y; Zhang M; Wang X; Hedstrom L; Cuny GD
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127543. PubMed ID: 32931912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.
    Kirubakaran S; Gorla SK; Sharling L; Zhang M; Liu X; Ray SS; Macpherson IS; Striepen B; Hedstrom L; Cuny GD
    Bioorg Med Chem Lett; 2012 Mar; 22(5):1985-8. PubMed ID: 22310229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase.
    Omolabi KF; Iwuchukwu EA; Agoni C; Olotu FA; Soliman MES
    J Mol Model; 2021 Jan; 27(2):35. PubMed ID: 33423140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum.
    Johnson CR; Gorla SK; Kavitha M; Zhang M; Liu X; Striepen B; Mead JR; Cuny GD; Hedstrom L
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1004-7. PubMed ID: 23324406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel adenosine-derived inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
    Shigetomi K; Sarwono AEY; Ichikawa S; Ubukata M
    J Antibiot (Tokyo); 2019 Dec; 72(12):934-942. PubMed ID: 31296916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of Cryptosporidium IMP dehydrogenase bound to an inhibitor with in vivo antiparasitic activity.
    Kim Y; Makowska-Grzyska M; Gorla SK; Gollapalli DR; Cuny GD; Joachimiak A; Hedstrom L
    Acta Crystallogr F Struct Biol Commun; 2015 May; 71(Pt 5):531-8. PubMed ID: 25945705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
    Gorla SK; Kavitha M; Zhang M; Chin JE; Liu X; Striepen B; Makowska-Grzyska M; Kim Y; Joachimiak A; Hedstrom L; Cuny GD
    J Med Chem; 2013 May; 56(10):4028-43. PubMed ID: 23668331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Basis of P131 Cryptosporidial-IMPDH Selectivity-A Structural, Dynamical and Mechanistic Stance.
    Omolabi KF; Agoni C; Olotu FA; Soliman MES
    Cell Biochem Biophys; 2021 Mar; 79(1):11-24. PubMed ID: 33058015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, in vitro evaluation and cocrystal structure of 4-oxo-[1]benzopyrano[4,3-c]pyrazole Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase (CpIMPDH) inhibitors.
    Sun Z; Khan J; Makowska-Grzyska M; Zhang M; Cho JH; Suebsuwong C; Vo P; Gollapalli DR; Kim Y; Joachimiak A; Hedstrom L; Cuny GD
    J Med Chem; 2014 Dec; 57(24):10544-50. PubMed ID: 25474504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico design of human IMPDH inhibitors using pharmacophore mapping and molecular docking approaches.
    Li RJ; Wang YL; Wang QH; Wang J; Cheng MS
    Comput Math Methods Med; 2015; 2015():418767. PubMed ID: 25784957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR and deep learning model for virtual screening of potential inhibitors against Inosine 5' Monophosphate dehydrogenase (IMPDH) of Cryptosporidium parvum.
    Asmare MM; Nitin N; Yun SI; Mahapatra RK
    J Mol Graph Model; 2022 Mar; 111():108108. PubMed ID: 34911011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and potent urea inhibitors of cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
    Gorla SK; Kavitha M; Zhang M; Liu X; Sharling L; Gollapalli DR; Striepen B; Hedstrom L; Cuny GD
    J Med Chem; 2012 Sep; 55(17):7759-71. PubMed ID: 22950983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural basis of Cryptosporidium -specific IMP dehydrogenase inhibitor selectivity.
    Macpherson IS; Kirubakaran S; Gorla SK; Riera TV; D'Aquino JA; Zhang M; Cuny GD; Hedstrom L
    J Am Chem Soc; 2010 Feb; 132(4):1230-1. PubMed ID: 20052976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triazole inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.
    Maurya SK; Gollapalli DR; Kirubakaran S; Zhang M; Johnson CR; Benjamin NN; Hedstrom L; Cuny GD
    J Med Chem; 2009 Aug; 52(15):4623-30. PubMed ID: 19624136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.
    Umejiego NN; Li C; Riera T; Hedstrom L; Striepen B
    J Biol Chem; 2004 Sep; 279(39):40320-7. PubMed ID: 15269207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.
    Gollapalli DR; Macpherson IS; Liechti G; Gorla SK; Goldberg JB; Hedstrom L
    Chem Biol; 2010 Oct; 17(10):1084-91. PubMed ID: 21035731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinetic alignment of orthologous inosine-5'-monophosphate dehydrogenases.
    Riera TV; Wang W; Josephine HR; Hedstrom L
    Biochemistry; 2008 Aug; 47(33):8689-96. PubMed ID: 18642884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved water-mediated recognition and dynamics of NAD+ (carboxamide group) to hIMPDH enzyme: water mimic approach toward the design of isoform-selective inhibitor.
    Bairagya HR; Mishra DK; Mukhopadhyay BP; Sekar K
    J Biomol Struct Dyn; 2014; 32(8):1248-62. PubMed ID: 23829371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
    Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
    J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.